Results 21 to 30 of about 892,444 (293)

Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research

open access: yesBMC Neurology, 2022
Objective To explore potential risk factors of preoperative cognitive dysfunction in adult patients with moyamoya disease (MMD) and discuss significance of moyamoya vessels.
Jian Sun   +4 more
doaj   +1 more source

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease [PDF]

open access: yes, 2017
Alterations of the dopaminergic (DAergic) system are frequently reported in Alzheimer’s disease (AD) patients and are commonly linked to cognitive and non-cognitive symptoms. However, the cause of DAergic system dysfunction in AD remains to be elucidated.
Aversa, D   +21 more
core   +3 more sources

Poor sleep quality and progression of gait impairment in an incident Parkinson’s disease cohort [PDF]

open access: yes, 2017
Abnormal sleep may associate with cognitive decline in Parkinson's disease (PD). Furthermore, sleep dysfunction may associate with worse motor outcome.
Anderson, Kirstie N.   +8 more
core   +2 more sources

Moderating Effects of Cortisol on Neural-Cognitive Association in Cognitively Normal Elderly Subjects

open access: yesFrontiers in Aging Neuroscience, 2017
Cortisol homeostasis is important for healthy brain and cognitive aging. The aim of the current study is to investigate the role of serum cortisol levels in the relationship between regional brain volumes and cognitive processing speed in a group of ...
Way K. W. Lau   +9 more
doaj   +1 more source

Evaluation of the determinants of cognitive dysfunction in patients with multiple sclerosis

open access: yesMiddle East Current Psychiatry, 2022
Background Cognitive dysfunction is common among patients with multiple sclerosis (MS); however, the determinants of cognitive dysfunction are still unknown.
Alireza Haji Seyed Javadi   +2 more
doaj   +1 more source

Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development. [PDF]

open access: yes, 2013
RationaleImpaired cognitive abilities are a key characteristic of schizophrenia. Although currently approved pharmacological treatments have demonstrated efficacy for positive symptoms, to date no pharmacological treatments successfully reverse cognitive
Acheson, Dean T   +2 more
core   +2 more sources

Evaluation and significance of cognitive dysfunction after cerebrovascular disease with convalescent rehabilitation. Assessment based on FIM, MMSE and HDS-R [PDF]

open access: yesBalneo and PRM Research Journal
To analyze the effectiveness of rehabilitation for patients with cognitive dysfunction after cerebrovascular disease at a rehabilitation hospital. 200 patients with cerebrovascular diseases who underwent rehabilitation were divided into two groups: 128 ...
Katsuo Usuda   +14 more
doaj   +1 more source

Moderators, mediators and nonspecific predictors of outcome after cognitive rehabilitation of executive functions in a randomised controlled trial [PDF]

open access: yes, 2017
Moderators, mediators and nonspecific predictors of treatment after cognitive rehabilitation of executive functions in a randomised controlled trial Objective: To explore moderators, mediators and nonspecific predictors of executive functioning after ...
Evans, Jonathan   +5 more
core   +1 more source

Cognitive Dysfunction in Multiple Sclerosis [PDF]

open access: yesFrontiers in Neurology, 2012
In Multiple Sclerosis (MS) prevalence studies of community and clinical samples, indicate that 45-60% of patients are cognitively impaired. These cognitive dysfunctions have been traditionally described as heterogeneous, but more recent studies suggest that there is a specific pattern of MS-related cognitive dysfunctions.
Joana eGuimarães   +3 more
openaire   +3 more sources

CA3 Induces Apoptosis of Hepatocellular Carcinoma HepG2 Cells and Related Mechanism

open access: yesZhongliu Fangzhi Yanjiu, 2020
Objective To investigate the effect of CA3(CIL56) on the proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and its mechanism. Methods HepG2 cells were cultured in vitro and treated with different concentrations of CA3 (0, 0.25, 0.5, 1.0,
ZHANG Shuwen   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy